Shane Kovacs - Nov 15, 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Ch. Operating & Financial Off.
Signature
/s/ Shane Kovacs
Stock symbol
OLMA
Transactions as of
Nov 15, 2024
Transactions value $
$175,500
Form type
4
Date filed
11/18/2024, 06:00 AM
Previous filing
Feb 5, 2024
Next filing
Dec 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $176K +25K +5.15% $7.02 510K Nov 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -25K -13.37% $0.00 162K Nov 15, 2024 Common Stock 25K $7.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 471 shares acquired under the issuer's Employee Stock Purchase Plan on June 28, 2024.
F2 25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.